These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27456091)

  • 61. Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome.
    Raskin L; Schwenter F; Freytsis M; Tischkowitz M; Wong N; Chong G; Narod SA; Levine DA; Bogomolniy F; Aronson M; Thibodeau SN; Hunt KS; Rennert G; Gallinger S; Gruber SB; Foulkes WD
    Clin Genet; 2011 Jun; 79(6):512-22. PubMed ID: 21155762
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
    Sessine MS; Das S; Park B; Salami SS; Kaffenberger SD; Kasputis A; Solorzano M; Luke M; Vince RA; Kaye DR; Borza T; Stoffel EM; Cobain E; Merajver SD; Jacobs MF; Milliron KJ; Caba L; van Neste L; Mondul AM; Morgan TM
    Urology; 2021 Oct; 156():96-103. PubMed ID: 34280438
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Commentary on: "Inherited DNA-repair gene mutations in men with metastatic prostate cancer." Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016 Aug 4;375(5):443-53.
    Lee BH
    Urol Oncol; 2017 Sep; 35(9):575-576. PubMed ID: 28789927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data.
    Fachal L; Gómez-Caamaño A; Celeiro-Muñoz C; Peleteiro P; Blanco A; Carballo A; Forteza J; Carracedo A; Vega A
    Prostate; 2011 Dec; 71(16):1768-79. PubMed ID: 21520156
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Elevated risk of prostate cancer among men with Lynch syndrome.
    Raymond VM; Mukherjee B; Wang F; Huang SC; Stoffel EM; Kastrinos F; Syngal S; Cooney KA; Gruber SB
    J Clin Oncol; 2013 May; 31(14):1713-8. PubMed ID: 23530095
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Germline Predisposition to Prostate Cancer in Diverse Populations.
    Bree KK; Hensley PJ; Pettaway CA
    Urol Clin North Am; 2021 Aug; 48(3):411-423. PubMed ID: 34210495
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer.
    Mannucci A; Zuppardo RA; Crippa S; Carrera P; Patricelli MG; Russo Raucci A; Calabrese F; Lazarevic D; Giannese F; Tonon G; Ferrari M; Testoni PA; Cavestro GM
    Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):345-349. PubMed ID: 31851094
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Commentary on "Inherited DNA-repair gene mutations in men with metastatic prostate cancer". Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016;375(5):443-53.
    Freedland SJ; Aronson WJ
    Urol Oncol; 2017 Aug; 35(8):536-537. PubMed ID: 28623070
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer.
    Moynihan C; Bancroft EK; Mitra A; Ardern-Jones A; Castro E; Page EC; Eeles RA
    Psychooncology; 2017 Nov; 26(11):1987-1993. PubMed ID: 28812325
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.
    Bancroft EK; Saya S; Page EC; Myhill K; Thomas S; Pope J; Chamberlain A; Hart R; Glover W; Cook J; Rosario DJ; Helfand BT; Hutten Selkirk C; Davidson R; Longmuir M; Eccles DM; Gadea N; Brewer C; Barwell J; Salinas M; Greenhalgh L; Tischkowitz M; Henderson A; Evans DG; Buys SS; ; ; Eeles RA; Aaronson NK
    BJU Int; 2019 Feb; 123(2):284-292. PubMed ID: 29802810
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Role of
    Pilarski R
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():79-86. PubMed ID: 31099688
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Germline and somatic DNA repair gene alterations in prostate cancer.
    Dall'Era MA; McPherson JD; Gao AC; DeVere White RW; Gregg JP; Lara PN
    Cancer; 2020 Jul; 126(13):2980-2985. PubMed ID: 32315455
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Familial prostate cancer.
    Giri VN; Beebe-Dimmer JL
    Semin Oncol; 2016 Oct; 43(5):560-565. PubMed ID: 27899188
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cancer risks for men with BRCA1/2 mutations.
    Mahon SM
    Oncol Nurs Forum; 2014 Jan; 41(1):99-101. PubMed ID: 24368245
    [No Abstract]   [Full Text] [Related]  

  • 75. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
    Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
    Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Carcinomas associated with Lynch syndrome: a family history.
    Pinar G; Ayhan A
    Int Surg; 2011; 96(4):286-90. PubMed ID: 22808608
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetically Informed Prostate Cancer Treatment for Metastatic Disease.
    Siebert AL; Szymaniak BM; Numan Y; Morgans AK
    Urol Clin North Am; 2021 Aug; 48(3):365-371. PubMed ID: 34210491
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Worldwide Practice Patterns in Lynch Syndrome Diagnosis and Management, Based on Data From the International Mismatch Repair Consortium.
    Pan JY; Haile RW; Templeton A; Macrae F; Qin F; Sundaram V; Ladabaum U
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1901-1910.e11. PubMed ID: 29702294
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention.
    Vietri MT; D'Elia G; Caliendo G; Resse M; Casamassimi A; Passariello L; Albanese L; Cioffi M; Molinari AM
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916521
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular insights into the germline for prostate cancer initiation, progression, and aggressiveness.
    Pritchard CC
    Can J Urol; 2019 Oct; 26(5 Suppl 2):24-26. PubMed ID: 31629422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.